{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:43:46Z","timestamp":1761803026842,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cardiacep.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiac Electrophysiology Clinics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.ccep.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T20:01:58Z","timestamp":1511380918000},"page":"775-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Subcutaneous Defibrillator"],"prefix":"10.1016","volume":"9","author":[{"given":"Jonathan","family":"Weinstock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Madias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ccep.2017.08.007_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.110.974170","article-title":"Predicting and preventing sudden cardiac death","volume":"124","author":"Estes","year":"2011","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ccep.2017.08.007_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.ccep.2017.08.007_bib3","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with\u00a0coronary disease at high risk for ventricular arrhythmia","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccep.2017.08.007_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ccep.2017.08.007_bib5","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"A\u00a0comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","year":"1997","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccep.2017.08.007_bib6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2011.06.007","article-title":"Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices","volume":"58","author":"van Rees","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.ccep.2017.08.007_bib7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of\u00a0>10 years","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccep.2017.08.007_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hrthm.2009.05.020","article-title":"Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA)","volume":"6","author":"Wilkoff","year":"2009","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ccep.2017.08.007_bib9","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","article-title":"Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator","volume":"10","author":"Knops","year":"2013","journal-title":"Heart Rhythm"},{"issue":"9970","key":"10.1016\/j.ccep.2017.08.007_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","article-title":"Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)","volume":"385","author":"Healey","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccep.2017.08.007_bib11","doi-asserted-by":"crossref","first-page":"e003181","DOI":"10.1161\/JAHA.115.003181","article-title":"Intraoperative defibrillation testing of subcutaneous implantable cardioverter-defibrillator systems\u2014a simple issue?","volume":"5","author":"Frommeyer","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ccep.2017.08.007_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter\u2013defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccep.2017.08.007_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry","volume":"65","author":"Burke","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ccep.2017.08.007_bib14","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ccep.2017.08.007_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ccep.2017.08.007_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study","volume":"10","author":"K\u00f6be","year":"2013","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ccep.2017.08.007_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/europace\/eut016","article-title":"United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn","volume":"15","author":"Jarman","year":"2013","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.ccep.2017.08.007_bib18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCEP.112.973339","article-title":"Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death clinical perspective","volume":"5","author":"Aydin","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"19","key":"10.1016\/j.ccep.2017.08.007_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ccep.2017.08.007_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00392-011-0303-6","article-title":"Clinical experience with a novel subcutaneous implantable defibrillator system in a single center","volume":"100","author":"Dabiri Abkenari","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"7","key":"10.1016\/j.ccep.2017.08.007_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ccep.2017.08.007_bib22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacep.2015.09.011","article-title":"Surgical management of implantation-related complications of the subcutaneous implantable cardioverter-defibrillator","volume":"2","author":"Brouwer","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"issue":"14","key":"10.1016\/j.ccep.2017.08.007_bib23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2007.09.073","article-title":"Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact","volume":"51","author":"Daubert","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccep.2017.08.007_bib24","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.hrthm.2014.04.025","article-title":"Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Groh","year":"2014","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1016\/j.ccep.2017.08.007_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/europace\/eut370","article-title":"How many\u00a0patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?","volume":"16","author":"Randles","year":"2014","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ccep.2017.08.007_bib26","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.hrthm.2014.04.012","article-title":"Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator","volume":"11","author":"Gold","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ccep.2017.08.007_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijcard.2015.05.135","article-title":"Inappropriate shocks in the subcutaneous ICD: incidence, predictors and management","volume":"195","author":"Nordkamp","year":"2015","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.ccep.2017.08.007_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.hrthm.2013.12.007","article-title":"Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management","volume":"11","author":"Kooiman","year":"2014","journal-title":"Heart Rhythm"},{"issue":"2","key":"10.1016\/j.ccep.2017.08.007_bib29","doi-asserted-by":"crossref","first-page":"e002488","DOI":"10.1161\/JAHA.115.002488","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy: an initial experience","volume":"5","author":"Weinstock","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.ccep.2017.08.007_bib30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCEP.113.000481","article-title":"Who should receive the subcutaneous implanted defibrillator? response to Jeanne E. Poole, MD, and Michael R. Gold, MD, PhD","volume":"6","author":"Poole","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.ccep.2017.08.007_bib31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/pace.12955","article-title":"Concomitant use of the subcutaneous implantable cardioverter defibrillator and a permanent pacemaker","volume":"39","author":"Huang","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ccep.2017.08.007_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hrcr.2015.03.014","article-title":"Successful implantation of a subcutaneous cardiac defibrillator in a patient with a preexisting deep brain stimulator","volume":"1","author":"Bader","year":"2015","journal-title":"HeartRhythm Case Rep"},{"issue":"11","key":"10.1016\/j.ccep.2017.08.007_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004633","article-title":"Subcutaneous implantable cardioverter-defibrillator shocks after left ventricular assist device implantation","volume":"9","author":"Pfeffer","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.ccep.2017.08.007_bib34","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIRCEP.113.000240","article-title":"Left ventricular assist device in a patient with a concomitant subcutaneous implantable cardioverter defibrillator","volume":"6","author":"Saeed","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"7","key":"10.1016\/j.ccep.2017.08.007_bib35","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacc.2008.04.051","article-title":"No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)","volume":"52","author":"Blatt","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ccep.2017.08.007_bib36","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"4","key":"10.1016\/j.ccep.2017.08.007_bib37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1540-8167.2011.02199.x","article-title":"Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study","volume":"23","author":"Gold","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"19","key":"10.1016\/j.ccep.2017.08.007_bib38","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccep.2017.08.007_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a\u00a0prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"}],"container-title":["Cardiac Electrophysiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918217301077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877918217301077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:40:14Z","timestamp":1761802814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877918217301077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1877918217301077"],"URL":"https:\/\/doi.org\/10.1016\/j.ccep.2017.08.007","relation":{},"ISSN":["1877-9182"],"issn-type":[{"type":"print","value":"1877-9182"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Subcutaneous Defibrillator","name":"articletitle","label":"Article Title"},{"value":"Cardiac Electrophysiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccep.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}